Ahmed Hegazi is currently a Professor of Microbiology and Immunology in the National Research Center, Egypt. He received his Master’s degree in 1979 and his PhD in 1981. His research work has been focused lately on bee products and their therapeutic effects. He organized and contributed to national and international research projects since 1977 and up till now; he has been the Principal Investigator on multiple research projects within the National Research Center. He has published 207 scientific papers and articles in national and international journals. He is also the President of the Egyptian Environmental Society for Uses and Production of Bee Products, Secretary of the Egyptian Society of Apitherapy, Secretary General of the African Federation of Apiculture Associations and a Member of the International Apitherapy Commission (APIMONDIA). He also received many awards.

Microbiology and Immunology

Tinatin Doolotkeldieva is a Head and Professor of Plant Protection Department of Agriculture Faculty at Kyrgyz-Turkish Manas University, Kyrgyzstan. She has expertise in Soil Microbiology, Bioremediation of Environment Pollution, Plant-Microbe interactions, Agricultural Biotechnology using molecular tools and management of plant health by using biocontrol agents. She has published more than 220 papers in reputed journals. She is a member of American Association for Microbiology, Molecular Plant- Microbe Interaction Society, British Plant Pathology Society, and Society for Invertebrate Pathology, ‘Global Avalon network “on organic agriculture and others.

She has expertise in Soil Microbiology, Bioremediation of Environment Pollution, Plant-Microbe interactions, Agricultural Biotechnology using molecular tools and management of plant health by using biocontrol agents.

Olga V.Kamzolkina is a russian mycologist, professor in the Mycology and Algology Department at Biology faculty of the Lomonosov Moscow State University. Kamzolkina OV founded a cyto-physiologists school for students and PhD students. Olga V. Kamzolkina is author of over 100 publications, several patents and books in the fields of cell biology, fungal cytology and physiology as well as fungal antimicrobial activity and ligth & electron microscopy. She is the member of the European Mycological Association and Obshchestvo Biotekhnologov Rossii Im. Yu.A. Ovchinnikova. She is currently studying fungal endocytosis, mithochondrial organization and functions in mycelial fungi from the different ecological niches. Lecture and laboratory course for bachelors and masters: fungal cell biology, physiology of fungi.

She is currently studying fungal endocytosis, mithochondrial organization and functions in mycelial fungi from the different ecological niches.

Zhiheng Pei is an Associate Professor in the Department of Pathology at New York University School of Medicine and serves as an Attending Pathologist in the Department of Veterans Affairs New York Harbor Healthcare System, USA. He has broad interests in the etiology and pathogenesis of cancers and chronic diseases. In the past several years, he has been evaluating and pioneering a new concept – microecological disease, in several NIH-sponsored projects involving cancers in the mouth, esophagus, and stomach as well as disease in tonsils. His laboratory defined the esophageal microbiome and demonstrated its association with esophageal adenocarcinoma in one of the Human Microbiome Demonstration Projects sponsored by NIH Roadmap Initiative. His team also discovered the link of periodontal pathogens to oral cavity squamous cell carcinoma. Clinically, he is interested in the diagnosis of diseases due to uncultivable microbial agents in fixed tissue specimens, using molecular techniques.

Clinically, he is interested in the diagnosis of diseases due to uncultivable microbial agents in fixed tissue specimens, using molecular techniques.

David Rabuka received a PhD in chemistry at the UC Berkeley as a Chevron Fellow in the lab of Carolyn Bertozzi. His research included developing and applying the SMARTagTM platform technology to cell surface modification. Prior to joining Bertozzi’s lab, David worked at the Burnham Institute synthesizing complex glycans followed by Optimer Pharmaceuticals, which he joined as an early employee, focused on the development of glycan and macrolide based antibiotics. He was CSO, President and co-founder of Redwood Bioscience where he developed novel protein conjugation methods and biotherapeutic applications such as antibody-drug conjugates. Redwood Bioscience was acquired by Catalent Pharma Solutions in Oct 2014, where David has continued to apply the SMARTagTM technology with various collaborators and partners as a Global Head of R&D. David graduated with a double honors BS in chemistry and biochemistry from the University of Saskatchewan, where he received the Dean’s Science Award, and holds an MS in chemistry from the University of Alberta. He is an author on over 45 major publications, as well as numerous book chapters and an inventor in over 30 patents.

His research interest is towards novel protein conjugation methods and biotherapeutic applications such as antibody-drug conjugates.

Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than two hundreds reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Turkey, France, Swiss, Germany, Sweden, Italy, Austria, Hungary, Poland, South Africa, Brazil, Spain, Portugal, Mexico, Japan, Singapore, Malaysia, Thailand, Taiwan, Hong Kong, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than eight hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than two hundreds reputed international academic–scientific–research institutes around the world. In addition, he is member of the Nobel committee for Chemistry. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.

Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure

Thomas McKeon has received his PhD in Biochemistry at UC Berkeley with Postdoctoral Research in Plant Biochemistry at UC Davis. He has over 100 publications, mostly in Plant Lipid Enzymology and Molecular Biology. He is an Editor and author for the book chapter “Industrial Oil Crops”. He is an Editor for Biocatalysis and Agricultural Biotechnology (BAB), a Board Member for American Oil Chemists Society (AOCS) Biotechnology Division and International Society for Biocatalysis and Agricultural Biotechnology (ISBAB). He has organized conferences for ISBAB and for US-Japan Natural Resources (UJNR) Food and Agriculture Panel.

Biocatalysis, Plant Biochemistry , Agricultural Biotechnology , Industrial Oil Crops

Sergey Suchkov, MD, PhD was born in 11.01.1957, a researcher-immunologist, a clinician, graduated from Astrakhan State Medical University, Russia, in 1980.Suchkov has been trained at the Institute for Medical Enzymology, The USSR Academy of Medical Sciences,National Center for Immunology (Russia), NIH, Bethesda, USA) and British Society for Immunology to cover 4 British university facilities. Since 2005, Dr Suchkov has been working as Faculty Professor of I.M. Sechenov First Moscow State Medical University and Of A.I.Evdokimov Moscow State Medical & Dental University. From 2007, Suchkov is the First Vice-President and Dean of the School of PPPM Politics and Management of the University of World Politics and Law. In 1991-1995, Dr Suchkov was a Scientific Secretary-in-Chief of the Editorial Board of the International Journal“Biomedical Science” (Russian Academy of Sciences and Royal Society of Chemistry, UK) and The International Publishing Bureau at the Presidium of the Russian Academy of Sciences. In 1995-2005, Suchkov was a Director of the Russian-American Program in Immunology of the Eye Diseases.Dr Suchkov is a member of EPMA (European Association of Predictive, Preventive and Personalized Medicine,Brussels-Bonn), a member of the NY Academy of Sciences, a member of the Editorial Boards for Open Journal of Immunology and others. Dr Suchkov is known as an author of the Concept of post-infectious clinical and immunological syndrome, co-author of a concept of abzymes and their impact into the pathogenesis of autuimmunity conditions, and as one of the pioneers in promoting the Concept of PPPM into a practical branch of health services.

Predictive, Preventive and Personalized Medicine,Immunology, Medicine, Pathology

Fuad Fares has completed his D.Sc studies at the Faculty of Medicine, Technion-Israel Institute of Technology, and postdoctoral studiesat the Department of Molecular Biology and Pharmacology, School of Medicine, Washington University, St. Louis Missouri. He is the director of the Department of Molecular Genetics at Carmel Medical Center and associated professor at the Department of Human Biology, University of Haifa. He has published more than 75 papers in reputed journals and serving as a member of the Israel Council for Higher Education. He is the inventor of designing long-acting recombinant proteins and the initiator of PROLOR Biotech company

Molecular Endocrinology Molecular Genetics Apoptosis cancer

lan Chet has completed his PhD in Microbiology at the Faculty of Agriculture of the Hebrew University of Jerusalem in Rehovot. He has published 390 articles, edited five books and holds 38 patents. He has served as a Dean of the Faculty of Agriculture and Vice President of the Hebrew University. Later, he was the President of the Weizmann Institute of Science and nominated “Institute Professor”. He was also a Visiting Professor at Harvard, Colorado State, Cornell, Rutgers and Lund Gottingen Universities. He was awarded with many prizes, among them, the Max-Planck, the Israel prize and the Wolf Prize. He has also received the Officer’s Cross of the Order of Merit of Germany and the Legion of Honor of France. Furthermore, he was recognized with an Honorary Doctorate from Lund, Haifa and Naples Universities. He is a Member of the Israel Academy of Sciences and Humanities, the European Academy of Sciences and Academia Europea. He held the previous position of Deputy Secretary General at the Secretariat of the Union for the Mediterranean.

His research concerns with the biological control of plant disease using environment-friendly microorganisms, focusing on the basic, applied, and biotechnological aspects of this field.

Dr Fernando de la Calle is currently the Head of the Microbiology Dpt. within Drug Discovery (R&D) at PharmaMar, biopharma involved in the development and commercialization of anticancer drugs of marine origin. He received his Ph.D. in Molecular Biology from UAM (Madrid) in 1998. He also completed an Executive-MBA at IDE-CESEM (Madrid) in 2005. He has more than 25 years’ experience working in drug discovery from marine microorganisms. He is an Expert in Applied Biotechnology, Molecular characterization of Bacterial Biodiversity and the use of Biotechnology tools for Drug Discovery . Co-author of the current hemisynthetic process for manufacturing the anticancer Yondelis®, the first European marine derived compound approved. In addition, he has been external advisor for biotechnology issues to the Spanish Government (INCUAL), current member of the International Advisory Group of european ERA-NET for Marine Biotechnology and Biodiversity, reviewer for H2020 and ERA-NET projects and the scientific contact person from PharmaMar for FP7/H2020 EU projects related to Marine Biodiversity such as MAMBA, MaCuMBA, MicroB3 and INMARE as WP leader. Principal Investigator in more than 10 other nationally funded projects.

Biotechnology, Molecular characterization of Bacterial Biodiversity and the use of Biotechnology tools for Drug Discovery

Liliana Rubio Chemical Engineer, Master in Project Management, MBA in Business Administration, MBA in Innovation Management, Specialist in polymer; over 18 years’ experience working on new business, R&D and marketing. Lecturer on innovation & sustainability at universities and the main trade fairs of polymer & Fashion Industry in Latin America, EUA and Asia. Author of several articles that have been publish in technology and business magazines.Founder of PMO Polymer Business Intelligence is a Project Management Office, located in Sao Paulo-Brazil, dedicated to project management consulting, mentoring, covering project planning, implementation and execution through a front-to-end creative quantification approach. Founder of SmartTex Hub ecosystem for the value chain of textile Industry and final applications.

Bio Composites,Nano Biotechnology

Dr. Tamboli was a Senior Agriculturalist at the World Banking, Washington, D.C., where he worked on projects in 30 countries in Africa and Asia. He also has held positions as a Soil Fertility expertat the Food and Agriculture Organization (link is external) (FAO) of the United Nations, and as a professor and associate dean at Jawaharlal Nehru Agricultural University at Jabalpur (link is external) (M.P.), and was involved in designing and implementing All India Agronomic Trials throughout India.

Environmental Science, Soil biology,Agricultural

Professor of Medical Microbiology & Immunology, Faculty of Medicine-Ain Shams University (ASU)&The Head of the department at Armed Forces College of Medicine. She participated in International research projects collaborated with Pasteur institute &Co-authored international Publications. Actively participated as an infection prevention and control consultant (APIC member#180759), in the upgrading of medical services and accreditation of governmental &teaching hospitals according to Egyptian standards. As an Associate trainer (IBCT-MENA-AT063/08), she trained their staff on infection control measures. She is an Arbitrator (Promotion Committee, Supreme Council of Universities), Vice president of quality assurance unit, ASU& Egyptian fellowship in healthcare management. She is a member in Egyptian Scientific Societies of Medical Microbiology, immunologists, Infection Control, Arabic Society of infectious diseases& antimicrobials. She passed medical education courses from University 0f Michigan and is a member in Arabic association of medical education. She had been recognized as the “Ideal doctor” Egyptian Medical Syndicate, March 2006.

Microbiology & Immunology

Nadiya Boyko has defended her PhD in 1994 and doctor degree in 2010. From 2000 until 2005 she occupied sabbatical Research Fellow position in Laboratory of Mucosal Immunology in University of Pennsylvania, USA. She is permanently working as professor at the Uzhhorod National University, and occupied following positions: Director of the R&D Centre of Molecular Microbiology and Mucosal Immunology; Vice-President and CSO of CLS in Slovakia and co-founder and CEO of Ediens LLC. Research interests are: P4 medicine, personalised nutrition, pharmabiotics, human microbiome, noncommunicable diseases; food safety, knowledge transfer. Co-establisher of Ukrainian and Slovak Technology Platforms “Agro-Food”; experienced stakeholder manager with links to industry, academia and researchers in Europe. She has published more than 250 papers, including chapter in Mucosal immunology Elsevier press, h-index is 10. Member: SMI, SOMED, ASA, SMU; Editor of SOMED, Microbial Journal and European Journal of Nutrition, and Guest Editor of Frontiers Immunology.

Microbiome of soil, plants and humans

Dr. Taha Nazir has more than twenty (20) years of professional, research and academic experience in the field of clinical and applied pharmacy including drug screening and disease transmission models. He is also specialist in clinical microbiology; infectious diseases; molecular basis of antimicrobial resistance development and resistance patterns. Moreover; He has experience of handling Biosafety level 2 and 3 biological samples and performed biological and biochemical analyses including quantitative PCR analysis, chromatographic and spectroscopic based assays. He also has strong background in data acquisition, writing, editing, reviewing and conceiving literatures related to clinical microbiology, pharmacology and clinical pharmacy at graduation and post-graduation level with excellent team player spirit and good leadership qualities.

Drug screening and disease transmission models, clinical microbiology; infectious diseases; molecular basis of antimicrobial resistance development and resistance patterns

Prof. Elasayed Elsayed Wagih (Ph.D, DIC, CIDTT) is a Professor of Virology and Biotechnology and Vice President of the Arab Society for Biotechnology. He was born in Alexandria, Egypt, on the 21st of November, 1946. In 1970, he received a B.Sc. in Plant Pathology from University of Alexandria and in 1975 he gained an M.Sc. degree in Plant Bacterial Diseases from the same university. In 1981, he received a PhD degree in Virology from the Imperial College of Science (Technology and Medicine), University of London and was awarded in the same year a DIC from the Royal College of Science. In March 2008, he earned The Cambridge International Diploma for Teaching and Training (CIDTT) from University of Cambridge, United Kingdom. Since June 26, 1992, Prof. Wagih has been working as Professor of Plant Pathology and Biotechnology in the Department of Plant Pathology, College of Agriculture,University of Alexandria, Egypt. He is the former Head of the Department and former Vice Director of research of the Biotechnology Centre of the College. He harvested a number of local and international awards, prizes and certificates of appreciation, the last most important of which was the "Highest National Award for Scientific Research Achievement" awarded by The Egyptian Academy of Science and Technology in 1998. Prof. Wagih served as a member of the National Committee for Promoting University Faculty for five successive years. He is also the former Representative of North Africa and a Board Member of the Governing Council of the African Crop Science Society (ACSS) for three successive interims. He has published over 80 papers most of them in reputable journals and is currently serving as Editor-In-Chief of the International Journal of Virology.

Virology and Biotechnology

Dr. Lazarovits was employed as a Research Scientist at Agriculture and Agrifood Canada from 1978 until 2010 and retired at a research scientist 5 level. He accepted the position as Research Director of a newly found company A&L Biologicals, a company dedicated to serving the needs of Canadian and International growers with services and research related to developing bio-rationale agro-ecosystems. Dr. Lazarovits’ research over the last decade has focused on examining plant health from an ecological perspective where both beneficial and detrimental organisms in soil are considered to affect plant vigor. He developed innovative model systems for studying soil processes and interactions between microorganisms and plants, as well each other. He serves on committees of Environment Canada and is a member of the UN Ozone Secretariat regulating the phase out of methyl bromide (MBTOC). Dr. Lazarovits was president of the Canadian Phytopathological Society. He was an active researcher and was a team leader with Agriculture and Agrifood Canada for over 32 years.

Developing bio-rationale agro-ecosystems

Stef Stienstra is a strategic and creative Consultant in Biomedical Science with a parallel career as a Commander of the reserve of the Royal Dutch Navy. For the Dutch Armed Forces he has responsibility for the counter measures in CBNRe threats and (Medical) consequence management both in a military and a civilian (terrorism) setting. He is a strategic functional specialist for “Health & Environment” of the 1-Civil-Military-Interaction Command (1-CMI) of the Dutch Armed Forces and for 2015 also in the NATO Response Force (NRF), which is in 2015 the responsibility of the 1-German-Netherlands-Corps (1-GNC). In his civil career he works internationally as Consultant or as Scientific Supervisory Board Member for several medical and biotech companies, merely involved in biodefense. He is also a Visiting Professor for Punjab University in Pakistan and Rhein-Waal University in Germany. He has completed his studies in Medicine and in Biochemistry at the University of Groningen in The Netherlands and has extensive practical experience in cell biology, immuno-hematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

Ebola

Eugenie Bergogne-Berezin is a Professor of Clinical Microbiology at University Diderot, Paris. She has studied MD in Medicine and PhD in Sciences in the early 1970s. She is a Chief of Department of Clinical Microbiology and research group, University Bichat Claude-Bernard and developed research on Acinetobacter spp., (nosocomial pathogen, pathogenicity, resistance), pharmacology of antibiotics, tissue distribution (lungs, brain, bronchi), research on intestinal ecology, jejunal flora and bacterial adhesion. She is an Adviser to pharmaceutical companies, expert in pharmacology-toxicology for the Ministry of Health, expert for international journals. She has developed a journal Antibiotics, (Elsevier). She has published 6 medical books, many chapters in international infectious diseases books, 200 articles in scientific journals.

Antibiotics

Dr. Theresa I. Dale, Ph.D., CCN, NP Founder & Dean, California College of Natural Medicine, Ventura, CA. President & CEO, The Wellness Center for Research & Education, Inc. Author * Inventor * Researcher * Biological Medical Consultant Dr. Dale’s interest in non-invasive therapies became her passion when she was diagnosed with a uterine tumor at 22 years of age. After healing herself of the tumor by herself in six months using only natural medicine, she decided to make natural medicine her career. She completed her Naturopathic Studies in Europe. In 1992 Dr. Dale founded The Wellness Center for Research and Education, Inc. The California College of Natural Medicine (501C3) was then founded to train health providers in advanced Biological Medicine. A Winning Combination! Dr. Dale is the “Pioneer of Hormone Rejuvenation” with over 20,000 case studies using her advanced formulas NuFem & EndoPure for Men and Women and her “Five Element Salivary Test” panel with her custom Wellness ProgramMoreover, Dr. Dale’s organic herbal and clean nutritional formulas have been proven successful in clinical testing. Furthermore, Advanced Homeopathic research lead to her formulation of the first Fibonacci Sequenced Homeopathic product line. She offers lectures and workshops to medical professionals and speaks at various conferences. Dr. Dale has authored two books “Revitalize Your Hormones; Dr. Dale’s 7 Steps to a Happier, Healthier and Sexier You” and "Transform Your Emotional DNA, Understanding the Blueprint of Your Life”.

non-invasive therapies

K C Santosh worked as a research fellow at the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). He worked as a postdoctoral research scientist at the LORIA research centre, Universite de Lorraine in direct collaboration with industrial partner ITESOFT, France, for 2 years. He also worked as a research scientist at the INRIA Nancy Grand Est research centre for 3 years, until 2011. K C Santosh has demonstrated expertise in pattern recognition, image processing, computer vision and machine learning with various applications in handwriting recognition, graphics recognition, document information content exploitation, medical image analysis and biometrics. He published more than 60 research articles, including a book section in encyclopedia of electrical and electronics engineering.

Electrical and electronics engineering

Lalit Garg has received his PhD degree from the University of Ulster, UK in 2010. He has received his first degree in Electronics & Communication Engineering from the Barkatullah University, India in 1999 and Postgraduate degree in Information Technology from ABV-IIITM, Gwalior, India in 2001. He is currently a Senior Lecturer in Computer Information Systems at the University of Malta, Malta. He was a Researcher at the Nanyang Technological University, Singapore and at the University of Ulster, UK. His research interests include missing data handling, machine learning, data mining and their applications especially in the healthcare domain. He has published more than 60 technical papers in refereed journals and conferences.

Electronics and communication engineering

Heather Medbury is a Senior Research Fellow at the University of Sydney, and is based at Westmead Hospital. She completed her PhD in transplant immunology before transferring to Vascular Biology to work for Professor John Fletcher, the head of Surgery for the University. Heather established laboratory based research for the Department of Surgery at Westmead Hospital which, combined with the large animal work operating in the Department, become known as the Vascular Biology Research Centre. Her work has received oral presentations at national and international meetings including at the American Heart Association (2004) and International Atherosclerosis Society meetings

Our research focus is cardiovascular disease. It is not just a global problem, but likely a personal one, as it doesn't just happen in someone else's family, but often within your own. Despite current treatments, patients with cardiovascular disease have a considerable residual risk of experiencing a clinical event (such as a heart attack or stroke). A challenge now is to develop strategies to prevent these remaining cardiovascular events. Though inflammation is thought to be a key contributor to residual risk, it is not a current treatment target. For the benefit of anti-inflammatory treatments to outweigh the risks, specific approaches will be required. A potential treatment target is the monocyte, as monocyte derived cells play a key role atherosclerotic plaque development and progression. Thus the focus of our group is to redefine the role of monocytes and macrophages in atherosclerosis in order to identify targets for therapeutic manipulation that could stabilize the disease. This will potentially result in a reduction in events such as heart attack and stroke that will not only decrease the morbidity and mortality associated with the disease, but also limit the associated, health, social and economic burdens it poses.

Noah Isakov is a Professor of Immunology and Chair of The Shraga Segal Department of Microbiology and Immunology at the Faculty of Health Sciences Ben Gurion University of the Negev Beer Sheva Israel. He received his PhD from the Weizmann Institute of Science in Rehovot Israel 1981 and performed postdoctoral studies at the University of Minnesota in Minneapolis MN 1981-1983 and the Scripps Research Institute in La Jolla CA 1983-1987. He performed a Sabbatical at the National Institute of Allergy and Infectious Diseases at the NIH Bethesda MD 1993-1995 and served as an Esther Z Greenberg Honors Chair in Biomedical Research at the Oklahoma Medical Research Foundation in Oklahoma City OK 2003-2004 and President of the Israel Immunological Society 2004-2006.

The general aim of our laboratory is to decipher signal transduction mechanisms that regulate T lymphocyte activation, function and differentiation into effector cells, as well as the characterisation of proto-oncogen products that are involved in cell transformation.

Kaihong Su is currently working as an Associate Professor in the Department of Pathology and Microbiology, College of medicine at University of Nebraska. Her research focuses on basic and translational research on autoimmune diseases. The ultimate goal is to understand the disease pathogenesis and identify novel biomarkers and pathways that can be developed into diagnostic/therapeutic tools for these diseases. She has completed her B.S., Nankai University (Microbiology), P. R. China, 1990 & M.S., from Nankai University (Microbiology), P. R. China in 1993. Ph.D., from University of Alabama at Birmingham (Cell Biology), Alabama, in 1998 & Post-doctoral training (Immunology) from University of Alabama at Birmingham, Alabama from 1998-2002

Immunology autoimmune diseases autoantibodies and neutrophils Research Interest

Ahmed Hegazi (or Ahmed Gaffer Hegazi; احمد جعفر حجازى) (born May 31, 1948) is currently a Professor of Microbiology and Immunology in the department of Zoonotic Diseases, National Research Center, Egypt. Prof. Hegazi received his masters degree in 1979, and his PhD in 1981. Hegazi's research work has been focused lately on bee products and their therapeutic effects. Hegazi Organized and contributed to national and international research projects since 1977 and up till now; he has been the principal investigator on multiple research projects within the National Research Center. He has published 166 scientific papers and articles in national and international journals. He also served on the board of multiple national and international scientific journals. Dr. Hegazi is also the president of the Egyptian Environmental Society for Uses and Production of Bee Products, secretary of the Egyptian Society of Apitherapy, secretary general of the African Federation of Apiculture Associations, and a member of the International Apitherapy Commission (APIMONDIA). Awards First Class Decoration of Excellence, Egypt, 1995 The Senior Scientist Prize of National Research Center, Cairo, Egypt, 1996 The National Scientific Prize In Biological Sciences, Egypt, 1990 The Scientific Prize of The National Research Center, Cairo, Egypt, 1989 The Second Best Research Paper Award, International Congress of Propolis, Bones Airs, Argentina, 2000 Main Speaker Award,10th Academic Conference, PRA and NAS (Nippon Apitherapy Soc.) Japan, 2006 2 Bronze medals from The International Innovation Fair of the Middle East, Kuwait, 2007 Patents Patent No. 8901 at 22/08/2006: A novel drug from natural products with new therapeutic modalities in treatment of psoriasis Patent No. 1005 at 02/01/2006: A novel drug from natural resources for controlling Fascioliasis Patent No. 270: at 01/06/2005: A novel drug from medicinal plants with antiatherosclerotic (hypocholesterolaemic), antioxidant and cardio protective properties. Patent No. 272: at 01/06/2005: A novel drug from natural resources with antiatherosclerotic (hypocholesterolaemic), antioxidant and cardio protective properties. Scientific Activities Editor in the following International Journals: Research Journal of Allergy, 2007 International Journal of Virology, 2007 Current Research In Tuberculosis, 2007 Research Journal of Veterinary Science, 2007 Research Journal of Microbiology, 2007 International Journal of Cancer Research, 2007 Research Journal of Medicinal plants, 2007 Referee in the following International Journals: Journal of Planta Medica, 2005 Journal of Evidence Based Complementary and Alternative Medicine, 2006 International Journal of Radiation Biology, 2007

Apitherapy, Immunology

Dr. Ian Martins has been invited to join the Editors of various international journals and has been a reviewer for various journals (approx. 40). He was appointed as the Chief Editor for International Journal of Diabetes Research (2014-2017). He is a BIT Member (BIT Congress. Inc) with an H-index of 42, (ResearchGate STATs (22), Mendeley STATS (20). The total citations over the past 27 years has accumulated to 2830. ResearchGate’s analysis available on google, Tweet, Facebook, Lindekin under Ian James Martins’ name places Dr Martins’ publication stats RG score higher than 96% of the international researchers and is now a SCIENTIST (ResearchGate). Dr Martins has received certificates of recognition at various conferences/congresses in relation to anti-aging medicine. Prevention of over eating by food restriction improves the peripheral sink hepatic abeta clearance relevant to liver lipid metabolism important to improving health and global chronic diseases.

Ethnopharmacology, Pharmacology

Dr. Mohamed Jahromi is currently working at Department of Pathology, Salmaniya Medical Complex, Bahrain. His research interest is based on Molecular Biology, Genetics, Biochemistry, Immunology, Cancer Biology, PCR, Western Blot, ELISA. He has published many articles in reputed journals.

Molecular Biology, Genetics, Biochemistry, Immunology, Cancer Biology, PCR, Western Blot, ELISA

Professor Tadamitsu Kishimoto is a world-renowned immunologist who was born in 1939 Osaka, Japan. After graduating from Osaka University Medical School in 1964, he completed a one-year internship at Osaka University Hospital, followed by Ph.D. studies in medicine from 1965 to 1969. Between 1970 and 1974, he pursued post-doctoral research in the Department of Medicine at Johns Hopkins Medical School, working under Professor Kimishige Ishizaka, the discoverer of IgE. He returned to Osaka University Medical School in Professor-Tadamitsu-Kishimoto1974 as assistant professor of medicine and progressed rapidly through his academic and research career becoming professor in 1979. He has served as dean and chairman of the Department of Medicine at Osaka University and was the university’s president from 1997-2003 and a Member of the Council for Science and Technology Policy from 2004 to 2006. Currently, he is professor of Immunology at the Immunology Frontier Research Center in Osaka University.

Post-transcriptional regulation of IL-6 has been largely uncharacterized, with the exception of the RNase Regnase-1, which prevents autoimmunity by destabilizing IL-6 mRNA

Current research projects are focused in study the complex relationships between the host and the microbiota and understand the foundations of innate immunity at a stage in which ZF larva rely 100% on it. For this porpoise we use germ-free or conventionally raised wild type or transgenic fish expressing fluorescent proteins under the control of specific promoters that further-on would be analyzed through live-imaging and molecular techniques, mainly qPCR.

raised wild type or transgenic fish expressing fluorescent proteins under the control of specific promoters that further-on would be analyzed through live-imaging and molecular techniques, mainly qPCR.

Veronica trained in medicine at St Mary’s Hospital, London. She has 3 certificates of specialist training (general medicine, respiratory medicine and clinical immunology and allergy). She has been a consultant at St Helier Hospital, Carshalton, Surrey since 1996. She was a Senior Registrar at Southampton General Hospital for 3 years, a Registrar at Royal Brompton Hospital for 3 years and at Papworth and Addenbrooks Hospital Cambridge for 2 years. Her research interests are Pulmonary fibrosis, Asthma and Anaphylaxis.

Her research interests are Pulmonary fibrosis, Asthma and Anaphylaxis. , General medicine, respiratory medicine and clinical immunology and allergy

Maulin P. Shah, currently Head and Senior Manager – Industrial Waste Water Research Lab, Division of Applied and Environmental Microbiology Lab at Enviro Technology Ltd., Ankleshwar, Gujarat, India, received his Ph.D. (2002-2005) in Environmental Microbiology from Sardar Patel University, Vallabh Vidyanagar, Gujarat. He has served as an Assistant Professor at Godhra, Gujarat University in 2001. He is a Microbial Biotechnologist with diverse research interest. A group of research scholars is working under his guidance on the areas ranging from Applied Microbiology, Environmental Biotechnology, Bioremediation, and Industrial Liquid Waste Management to solid state fermentation. His work has been focused to assess the impact of industrial pollution on microbial diversity of wastewater following cultivation dependant and cultivation independent analysis. His major work involves isolation, screening, identification and Genetic Engineering of high impact of Microbes for the degradation of hazardous materials. He has more than 140 research publication in highly reputed national and international journals. He directs the Research program at Enviro Technology Ltd., Ankleshwar. He has guided more than 20 Post Graduate students in various disciplines of Life Science. He extends his expertise in various National as well as International Reputed Journal as Editor and Editorial Board Member like Open Access Book of Cloud Publication, Journal of Environment Pollution and Human Health. He was Founder Editor-in-Chief of International Journal of Environmental Bioremediation and Biodegradation (2012-2014) as well as Journal of Applied and Environmental Microbiology (2012-2014) (Science and Education Publishing, USA), Editorial Board Member of American Journal of Microbiological Research, Electronic Journal of Energy and Environment, International Journal of Environment and Sustainability. He is also serving as a reviewer in various journals of national and international repute. Recently, he has been appointed as a Reviewer in Nature Biotechnology Journal.

Environmental Microbiology, Bio-remediation, Bio-degradation, Industrial Waste Water Treatment, Applied Microbiology, Enzyme Engineering, Liquid to Solid State Fermentation, Waste Water Genomics

Gregory Lee received his Ph. D from the California Institute of Technology and completed his postdoctoral studies at the University of California, San Diego. He became a full Professor at the University of British Columbia in 1989, and retired in 2012 with the title of Professor Emeritus. He is the co-founder of Vancouver Biotech Ltd. He has published more than 200 papers, including 30 papers in cancer research. He has been serving as an editorial board member of the Journal of Carcinogenesis and Mutagenesis, and the Journal of Cancer Science and Therapy since 2012.

Antigen receptors, including immunoglobulins and T-cell receptors

Steven Pincus obtained his B.S. and Ph.D.in Biochemistry from the State University of NY at Buffalo. His Ph.D. thesis project involved studies on the mechanism of Adenovirus DNA replication and he gained experience growing and purifying and tittering multiple Adenovirus serotypes. He obtained his post-doctoral training in the microbiology department at the State University of NY at Stony Brook under an NIH Fellowship studying inhibitors of picornavirus replication and gained experience in the growth and purification of and titration Poliovirus and growth of other picornaviruses. He then joined Virogenetics where he was Senior Scientist and Platform Leader in Molecular Biology and Microbiology.

He then joined Novavax, Inc., a biotech focusing on the development of vaccines against Influenza and Respiratory Syncytial Virus (RSV), based on Virus-Like Particle (VLP) platform vaccine technology. There he was responsible for analytical development, quality control and quality assurance, and recombinant baculovirus production. He was a key member of the team that secured a contract award valued at up to $179 million by the Office of Biomedical Advanced Research and Development Authority (BARDA) for the advanced clinical and manufacturing development of recombinant vaccines for the prevention of seasonal and pandemic influenza. He has consulted for several companies in the areas of assay development, transfer, qualification and validation for monoclonal antibody and vaccine projects.

Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President Foundation de Beaumont Bonelli for Cancer Research.

His research interest are Viral Oncology, Tumor Liberated Protein (TLP), Emerging Viral Agents at Risk in Global Health Approaches to Early Diagnosis and Prompt Therapy.

Dr. M. Tary-Lehmann is an Adjunct Associate Professor of Case Western Reserve University (CASE) Department of Pathology, Co-Founding Scientist and Chief Scientific Officer for Cellular Technology Limited (CTL). She has published more than 75 papers in peer-reviewed journals. She provides guidance and oversight for technical operations in the GLP laboratory, ensuring the ongoing scientific excellence of CTL. Over the past decade, she has worked with clients and regulatory agencies to develop and validate reference samples and controls for use in regulated immune monitoring assays.

Vaccines & Vaccinations

NUMAZAKI, KEI, Physician & Microbiologist; born in Sapporo, Hokkaido, Japan; MD, Sapporo Med. U., 1980, PhD, 1985. Staff Pediatrician Hokkaido Children’s Hospital, 1985-1986; Postdoctoral Fellow McGill U., Montreal, Can., 1986-1989, Adjunct Prof., 1994-2004 ; Sr. Lectr. Sapporo Med. U., 1990-1993, Asst. Prof., 1993-2004, Assoc. Prof., 2004; Chief of Measles Laboratory, Virology III, National Institute of Infectious Diseases, Tokyo, Japan, 2004-2008; Head of Regional Reference Laboratory and Global Specialized Laboratory, WHO, Geneva, 2005-2008; Professor & Chair, Division of International Infectious Diseases, Graduate School, Departments of Pediatrics, University Hospital, International University of Health and Welfare, Tochigi, Japan, 2008-present. Country Ambassador for Japan of Am. Soc. Microbiology (ASM), Avocations: Skiing, Marathons

Pediatric infectious diseases, Vaccine study Viral pathogenesis and diagnostic microbiology clinical and microbiological studies especially in the field of Human cytomegalovirus,Chlamydia (trachomatis and pneumoniae) Mycoplasma pneumoniae, HIV, Human rotavirus, Measles, Rubella infections.

My academic evolution was realized at the Faculty of Pharmacy of the University of Conakry, Guinea (1968-1973; PharmD in 1973), the Institute of Pharmacy (Free University of Brussels, Belgium ;1983-1986), the Tropical Medicine Institute of Antwerp, Belgium (1985-1987), the Department of Pharmaceutical Sciences, University of Antwerp, Belgium (1986-1991; PhD in 1990). I’ve been the chief of the department of pharmacy (University of Conakry) from 1998 to 2010 and I’m the General Manager of the Research and Valorization Center on Medicinal Plants (Dubreka) since 2000. As a full professor, I’m teaching pharmacognosy, ethnopharmacology and phytochemistry to students of pharmacy, biology and chemistry in the Guinean universities.

Since 1973, my efforts on epidemiological and ethnopharmacological investigations on infectious and non- infectious diseases led to the development of some antimalarial, antihypertensive, antidiabetic, antischistosomiasis and antiHIV/aids phytomedicines. I’ve more than 60 international publications and I’m owner of two patents about antihypertensive and antidiabetic phtomedicines. My research interest is mainly focused on ethnomedical, ethnobotanical, biological, phytochemical studies and clinical trials based on Guinean plant species.

Jorge Alberto Panameno Pineda has completed his Medical Doctorate in 1990 at Universidad Evangelica of El Salvador followed by his Internal Medicine Residency at the Salvadorian Institute of Social Security and a Master of Science in Tropical Medicine and Infectious and Parasitic Diseases at the University of Brasilia, Brazil in 1996. Currenty he is the Executive Director of the Fundación Salvadoreña para la Inmunoinfectologia y Medicina Tropical, a non-profit organization dedicated to research infectious and parasitic diseases and vaccinology. He was awarded the World Health Travel Award funded by the Bill and Melinda Gates Foundation in 2012.

Research Infectious and parasitic diseases

Antonio Mastroianni, M.D,Jul 1996—-present, is currently working as a medical physician specialist in Infectious Diseases & Tropical Diseases with a “high degree in antibiotic and antifungal treatment” at Presidio Ospedaliero “G.B. Morgagni – L. Pierantoni”, Dipartimento di Medicina Specialistica, Unità Operativa Malattie Infettive, Forlì, Italy

Diagnosis and Management of Sepsis and Septick Shock (Milano University, 2010) Infectious Diseases in Pregnant Women, Fetuses and Newborns, (ESCMID Postgraduate Education Corse, Bertinoro-Bologna University 2013) Epidemiology, Diagnosis and Management of Sexually Transmitted Infections (Italian Society of Clinical Microbiology, Working Group on the Sexually Transmitted Infections, Bertinoro-Bologna University 2012, 2014)

Professor George L. Mendz has an MSc from the University of Barcelona (Spain), and a PhD from the University of NSW. He has been Lecturer at the College of Natural Sciences, the University of Puerto Rico (San Juan); Research Associate at the School of Chemistry and the Department of Biochemistry, the University of Sydney; ARC Senior Research Fellow and Associate Professor at the School of Biochemistry and Molecular Genetics, the University of NSW; Associate Professor at the Department of Bacteriology, the University of Bordeaux II; and Associate Professor at the School of Medical Sciences, the University of NSW.

More recently, he had acquired expertise in global analyses involving proteomics and transcriptomics by investigating microorganism responses to stress, as well as in bacterial genome sequencing and the application of metagenomics to characterise bacterial populations.

1996-present: Director, WM Keck Center for Transgene Research, University of Notre Dame. 1983-present: Kleiderer/Pezold Professor of Biochemistry, University of Notre Dame. 1979-2002: Dean, College of Science, University of Notre Dame. 1977-1983: Professor, University of Notre Dame. 1974-1977: Associate Professor, University of Notre Dame. 1970-1974: Assistant Professor, University of Notre Dame. 1968-1970: NIH Postdoctoral Fellow, Duke University. 1968: Ph.D. in Biochemistry, University of Iowa. 1964: B.S. University of Scranton. 2006-present: Adjunct Professor of Biochemistry & Molecular Biology, Indiana University School of Medicine.

The interests of Professor Castellino\'s laboratory involve the structure, function and activation of proteins that participate in blood coagulation and blood clot dissolution. The in vivo mechanisms of the roles of these proteins in these processes are being addressed through in vivo targeted gene-replacement approaches and corresponding in vitro structure-function studies on these genes and proteins are being studied by the most modern biophysical techniques, e.g., X-ray crystallography, NMR, etc. Most of these proteins exist in an inactive state in plasma and thus must be activated to enzymes to exhibit their functional properties. The molecular events involved in the activation and analysis of the concomitant structural changes that occur in the protein are investigated by modern biochemical techniques. Major tools of the laboratory involve cloning, mutagenesis and expression of variant recombinant proteins and individual protein domains, immunochemical studies of the proteins, as well as physical and chemical analysis of their solution structures. The properties of the proteins are then related to their functions. Another project receiving attention involves the structure-function relationships of small gamma-carboxyglutamic acid (Gla)-containing peptides from marine cone snails that target the brain NMDA receptor. These peptides inhibit the flow of calcium into neuronal cells, this latter event being responsible for the neuropathology associated with stroke, epilepsy, Alzheimer\'s Disease, ALS, etc. The biochemical, pharmacological and neurobiological mechanisms of the actions of these peptides are under study. Peptide synthesis, receptor binding, molecular biological and electrophysiological tools are currently employed in this work. To determine the biological functions of genes encoding coagulation and clot-dissolving proteins in hemostasis, cancer, inflammation, wound healing, embryonic implantation and development, metastases, and athersclerosis, gene deletion and other gene targeting experiments are being performed in mice, in conjunction with phenotyping of these animals. Such studies are expected to provide important information on the development and progression of these disease states.

Dr. Joshi is director of center for surgical infections and biofilms. He is an associate professor in the Departments of Microbiology & Immunology and Dermatology, and Surgery, and an adjunct professor at the A.J. Drexel Plasma Institute, as well as Drexel's School of Biomedical Engineering. He has a special interest in emerging bacterial infections, novel disinfection and sterilization techniques, and biodefense bacterial vaccines. Since 1987, Dr. Joshi has taught undergraduate, postgraduate and doctoral students, and trained doctoral and postdoctoral, residents and fellows for research. He has been mentoring graduates and medical students, who now have successful careers in medicine, academia and the pharmaceutical industry. Since 2004, he has been a member of international mentoring program and minority mentoring program of American Society of Microbiology (ASM), and Infectious Disease Society of America (IDSA). He is physician-researcher-teacher, and eligible member of American Board of Medical Microbiology.

Emerging bacterial infections, host-pathogen interactions, hospital-acquired infections, antimicrobial drug resistance, novel infection control strategies, carbapenem-resistant Acinetobacter baumannii, botulism & bacterial biofilms

Dr. Ananda M. Chakrabarty serves as Senior Science Advisor of Amrita Therapeutics Limited. Dr. Chakrabarty is a Amrita’s Senior Science Mentor and Global Domain Expert relating to how bacterial proteins effectively combat cancers, parasites, and viruses in the human body. Dr. Chakrabarty serves as a Distinguished University Professor of Microbiology and Immunology at the University of Illinois College of Medicine, and advises senior officials in the U.S. and abroad on policies relating to biotechnology and related technology transfer. He is a Consultant to the United Nations. In 1980, Dr. Chakrabarty’s genetically modified Pseudomonas bacteria became the first genetically-engineered organism to gain a patent, as a result of the Supreme Court decision in Diamond vs. Chakrabarty. Dr. Chakrabarty undertook pioneering biotechnology research into the therapeutic potential for protein products of bacteria, both at the University of Illinois at Chicago (UIC) and on behalf of CDG Therapeutics, a U.S. biotechnology start-up company engaged in clinical cancer research. Dr. Chakrabarty has led path-breaking research into the therapeutic qualities of protein products of bacteria. His work includes recent studies with water-soluble products of pathogenic bacteria demonstrating significant promise for cancer therapies, effective against HIV/AIDS, malaria and perhaps even tuberculosis. Dr. Chakrabarty was a part of the Advisory Committee that resulted in creation of the International Center for Genetic Engineering and Biotechnology (ICGEB) in Trieste, Italy and rejoined the ICGEB Advisory Board. Dr. Chakrabarty has numerous publications and has received many notable awards for his contributions to biotechnology, including Padma Shri in 2007, one of the Indian Government’s highest civilian honors.

Cell Biology, Microbiology, Pseudomonas aeruginosa, Cancer Cells, Biotechnology, Oncology, Cancer Biology, Cancer Therapy, Pseudomonas, Malaria, Cystic Fibrosis, Genetic Engineering, Infectious Diseases, Cancer Chemotherapy, Mutation

Akira Kaji is a professor of microbiology, School of Medicine, University of Pennsylvania. He contributed to the deciphering of genetic code by his discovery of the fact that the complex of poly-U with ribosome binds specifically tRNA specific for phenylalanine. He also discovered RRF.

The following is a short review of Akira Kaji past work. In 1963, they discovered that specific tRNA binds to the complex of mRNA and ribosome. This finding was essential to decipher the genetic code (9). Regarding RRF, upon in vivo inactivation of RRF, the ribosome starts the unscheduled translation downstream from the termination codon. Crystal structure by X-ray crystallography as well as solution structure by NMR has revealed that RRF is a near perfect structural mimic of tRNA. Indeed, we found that RRF functionally mimics tRNA in that it moves in the inter-subunits space like tRNA does. However, the mode of RRF binding to the ribosome is different from that of tRNA. We also discovered arginyl-tRNA protein transferase in 1963(10). This enzyme is an essential for higher eukaryotes and involved in post-translational protein modification.

Awards RESEARCH & SCHOLARSHIP AWARDS 2015 Fellow of the American Academy of Microbiology 2014 Faculty Excellence Award (one award given per year within the School of Molecular and Cellular Biology at the University of Illinois). 2004 Award for Excellence in Research and Scholarship at the Associate Professor Level - University of Houston (one university award per year at each academic rank). 2002 Award for Excellence in Research and Scholarship at the Assistant Professor Level - University of Houston (one university award per year at each academic rank).  1999 Young Investigator Award, 10th International Meeting Campylobacter & Helicobacter. 1997 Natural Science and Mathematics Alumni Association Award. 1996 Oakridge Junior Faculty Award for Life Sciences Research. 1981 NSF Undergraduate Research Award. TEACHING AWARDS AND RECOGNITION 2010, 2013 Cited as a Teacher ranked as outstanding by their students for Molecular and Cellular Biology/Life Sciences and College of Medicine Courses. 2008, 2009 Cited as a Teacher ranked as excellent by their students for Molecular and 2011, 2012 Cellular Biology/Life Sciences and College of Medicine Courses. 1999 Teaching Excellence Award, College of Natural Sciences and Mathematics. 1998-1999 University of Houston Enron Award for Excellence in Teaching at the University level. RECENT LECTURESHIPS, MEETING CHAIRS, LEADERSHIP POSITIONS 2015 Vice-Chair, Gordon Conference on Chemical & Biological Terrorism Defense, Ventura, CA, March 2015. 2013 Chair, Bacteria-Host Interactions (2013) 2013 International Conference on Bacillus anthracis, B. cereus, and B. thuringiensis, Victoria, Canada, September 2, 2013. 2013-2014 Chair, Division B (Microbial Pathogens) of ASM. 2013 Discussion Leader/Session Chair, Organizing Committee, 2013 Gordon Conference on Chemical & Biological Terrorism Defense, Ventura, CA, March 10-15, 2013. 2012-2013 Chair Elect, Division B (Microbial Pathogens) of ASM, 2012-2013. 2011 Session Chair, Organizing Committee, 2011 International Conference on Campylobacter, Helicobacter, and Related Organisms, Vancouver, British Columbia, Canada, August 28 – September 1, 2011. 2011 Keynote Speaker, 23rd Annual Buffalo Conference on Microbial Pathogenesis – Witebsky Center for Microbial Pathogenesis and Immunology (2011) Of Persistence, Cancer, and Asthma: The Curious Case of Helicobacter pylori, Buffalo, NY, April 29, 2011. 2011 Organizing Committee, and Discussion Leader/Session Chair, 2011 Gordon Conference on Chemical & Biological Terrorism Defense, Ventura, CA, March 20-25, 2011.

Genetics, Host-Pathogen Interactions, Membrane Biology, Microbial Physiology, Molecular Immunology, Receptor Biochemistry, Signal Transduction, Toxins

Dr. Kei Amemiya is a Principal Investigator in the Bacteriology Division at the US Army Medical Reseach Institute of Infectious Diseases. He has been at USAMRIID since 1999 and has been involved in developing vaccine candidates against plague, glanders, and melioidosis. His interest has been in studying the host’s immune response to the pathogen and vaccines in small and large animal models. Before coming to USAMRIID, he was at the National Institutes of Health and Georgetown University, where he was studying the host response to bacterial and viral pathogens or autoimmune diseases in humans.

Molecular Biology, Immunology, Microbiology, Infectious Diseases

Dr. Goc obtained her M.S. and Ph.D. from the Jagiellonian University, Cracow, Poland. She conducted her postdoctoral training at Case Western Reserve University, Cleveland, OH, and the University of Georgia, Athens, GA. She also worked as a Research Biologist at the VA Medical Center, Augusta, GA. Currently, as a Head of Infectious Diseases Division at Dr. Rath Research Institute, Santa Clara CA, she leads a Lyme disease project. Dr. Goc has published over 30 peer-reviewed publications, two book chapters, and has presented her research at numerous national and international scientific meetings. She is also an active member on one editorial board and the recipient of several national and international awards.

Molecular biology, biochemistry and cell biology in the fields of microbiology, immunology, cancer, and vascular biology

Wanda C. Reygaert is an Associate Professor of Microbiology and Immunology in the Biomedical Sciences Department at Oakland University William Beaumont School of Medicine. Dr. Reygaert earned her B.S. in Biology/Medical Technology from Indiana University, an M.S. in Biology/Microbiology from Purdue University, and a Ph.D. in Molecular Biology from the University of Illinois at Chicago. She has been a member of the American Society for Clinical Pathology (ASCP) since 1993, and a member of the American Society for Microbiology (ASM) since 1999. Dr. Reygaert joined the OUWBSOM as a founding faculty member in the Fall of 2009.

Biology/Microbiology, Clinical Pathology

Mohamed K. Fakhr, is currently an Associate Professor of Molecular Microbiology in the Department of Biological Science at the University of Tulsa, USA. After obtaining his Ph.D. from Oklahoma State University in 2002, Dr. Fakhr, moved to North Dakota State University where he worked as a Postdoctoral Research Associate then a Research Assistant Professor at the Department of Veterinary and Microbiological Sciences. In 2008, Dr. Fakhr moved to Tulsa, where he currently runs an active research program in the area of Molecular Typing and Detection of Foodborne Bacterial Pathogens alongside exploring the mechanisms by which these foodborne pathogens develop resistance to antimicrobials.

Microbiology, Biological Science, Veterinary Science

Dr. Ling Zhan is a pediatric dentist and professor who cares for children and adolescents at both the Mission Bay and Parnassus campuses. Her treatment philosophy is very prevention-oriented. She works closely with her patients and their families to identify risk factors for common dental diseases, such as dental caries, and to adopt scientifically-based preventive and treatment regimens to avoid future diseases. Her practice provides routine as well as complex care, including care for children with dental or medical conditions who require treatment under sedation or general anesthesia. She works closely with other dental specialties to treat children with complex dental disease, such as amenogenesis imperfecta. In addition to patient care and education, Zhan conducts clinical and translational research projects that are focused on microbiological aspects of tooth decay; oral prevention programs guided by risk assessment; and identification of protocols to prevent or eliminate dental caries in children. Zhan completed her pediatric dentistry residency training at UCSF. She is a member of the American Academy of Pediatric Dentistry and a diplomate of the American Board of Pediatric Dentistry.

Pediatric Dentistry, microbiological aspects of tooth decay, dental diseases

Timms is Professor of Microbiology and Director of Research at QUT’s Institute of Health and Biomedical Innovation in Brisbane Australia. He is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all aspects of chlamydial infections. Timms has published over 170 refereed journal papers and is editor of the journal, Pathogens and Disease.

He leads a well established research team of 10 people. His research group is developing vaccines and new diagnostics for chlamydial diseases in humans and animals as well as an improved understanding of chlamydial genomics, cell biology and pathogenicity. The group is widely acknowledged for its major contributions to chlamydial infections in koalas and other wildlife, including the development of a vaccine for koalas.

Liaqat Ali Chaudhry completed MBBS from King Edward Medical College university Lahore1981. He completed his post-graduation in Diploma in Tuberculosis & Chest Diseases -Punjab University Lahore-Pakistan, MCPS from College of Physicians and Surgeons Pakistan and MRCP, FRCP from The Royal College of Physicians Dublin-Ireland. He worked as house physician, Registrar, Assistant professor at King Edward Medical College Lahore, 1982-1987. Later he joined MOH of Saudi Arabia worked as Specialist Physicians chest specialist on Feb-1988, Consultant Pulmonologist and Chief of Tuberculosis Center, Dept. of Internal Medicine & Chest diseases Dammam medical complex and Honorary Associate & Professor Dammam Medical University, Eastern Province K. Saudi Arabia – 2011 and Chairman Internal Medicine & Consultant Invasive.

Consultant Pulmonologist and Chief of Tuberculosis Center, Deptt.of Internal Medicine & Chest diseases Dammam medical complex and Honorary Associate & Professor Dammam Medical University, Eastern Province K.Saudi Arabia.

Dr. Kuo-Chen Chou is the founder of Gordon Life Science Institute. He is also a Distinguished High Impact Professor and Advisory Professor of several Universities. Professor Chou has published over 510 papers in the fields of computational biology and biomedicine, protein structure prediction, low-frequency internal motion of protein and DNA and its biological functions, diffusion-controlled reactions of enzymes, as well as graphic rules in enzyme kinetics and other biological systems. Professor Chou’s awards include: “Medal of Science and Technology” (awarded by Shanghai Congress of Science & Technology, 1977); “National Science Medal” (awarded by the National Academy of Sciences, China, 1978); “The Scientist with the most number of hot papers (2007-2008) in the world” (honored by Web of Science, 2008); “The high impact distinguished professor” (honored by the Center of Excellence in Genomic Medical Research, 2013); “2014 Highly Cited Researcher in the field of Biology & Biochemistry and Computer Science” (honored by Thomson Reuters); “2015 Highly Cited Researcher in the field of Biology & Biochemistry” (honored by Thomson Reuters). According to ISI Science Citation Index (Web of Science), as of January 2015, Professor Kuo-Chen Chou's publications have been cited more than 33,084 times with h-index of 99. According to Google Scholar Citations, his papers have been cited more than 40,720 times with h-index of 112.

Computational Biology, Bioinformatics, Biomedicine, Protein Structure Prediction, Low-frequency internal motion of Protein and DNA and its biological functions, diffusion-controlled reactions of enzymes, as well as graphic rules in enzyme kinetics and other biological systems

Maria Vittoria Cubellis graduated in Chemistry from the University of Naples and obtained the PhD in Biochemistry. She is professor of Biochemistry and Bioinformatics at the University "FedericoII" of Naples.

Her recent research interests are focused on pharmacological chaperones for the treatment of rare diseases and in particular on the prediction of mutations associated to Fabry disease which are responsive to drugs. She is also trying to extend the approach with pharmacological chaperones to other pathologies, such as disorder of glycosylation type 1a, a disease for which there is no cure at present.

Dr. Deodutta Roy joined Florida International University as a Professor in 2004 and as a founding Chairman he established a new Department of Environmental and Occupational Health. Dr. Roy received both his Master of Philosophy (1980) and PhD (1984) in Life Sciences from the Jawaharlal University, New Delhi, India. Dr. Roy is a prolific scholar and researcher, having published over one hundred peer reviewed articles, book chapters, monographs, and two patents, and has trained 15 doctoral students and numerous postdoctoral fellows. Since last 24 years, his research program has been continuously funded through grants from the American Cancer Society, US National Institutes of Health (NIH), the Department of Defense (DoD), or Veteran Affairs. Dr. Roy has served on a variety of research-related advisory boards and review panels, including NIH, DoD, the Susan Komen Foundation, Miami VA, and the Massachusetts Public Health Breast Cancer review panels. Dr. Roy is also on the editorial boards of nine scientific journals.

Dr. Roy’s ongoing research is focused on identifying biological pathways and networks contributing to the susceptibility of cancer and neurodegenerative diseases with the goal of identifying suitable drug targets and potential therapeutics.

Costas Iliopoulos is Head of the Algorithms and Bioinformatics group at the Kings College, London. He has completed his Ph.D. and M.Sc. in Computer Science, University of Warwick, Coventry, England. He is the Director of M.Sc. programme. He has published 200 papers and serving as an editorial board member for the Journal of Discrete Algorithms and Journal of Computer Mathematics and Combinatorial Computing.

Iliopoulos’s research interests include Design and Analysis of String Algorithms, Algorithms for Molecular Sequences.

Elena Papaleo received her PhD in 2006 and did her postdoctoral works from 2007-2009 at the Department of Biotechnology and Bioscience at the University of Milano-Bicocca (Italy) in the group of Prof. Luca De Gioia and Prof. Piercarlo Fantucci. She was then appointed Adjunct Professor in Computational Biology at the University of Milano-Bicocca from 2010 to 2012. Afterwards, she was senior Post-Doctoral Researcher in the group of Prof. Lindorff-Larsen at the Department of Biology of the University of Copenhagen (Denmark) from 2011 to 2015. She has been Visiting Researcher at many international institutes including the group of Prof. Salvador Ventura at the Institute of Biotechnology and Biomedicine (IBB, Barcelona, Spain) and the group of Prof. Francesco Luigi Gervasio at The Spanish National Cancer Research Center (CNIO, Madrid, Spain). In August 2015, she joined as Group Leader of the Computational Biology (CBL) Laboratory at the Danish Cancer Society Research Center (Copenhagen, Denmark). She has authored more than 50 scientific papers as main or senior author and she is Academic Editor of PLoS One, Frontiers in Molecular Biosciences (Nature publishing group), PeerJ and Journal of Molecular Graphics and Modelling.

Her research works deals with molecular modelling and simulations integrated with experimental data and network theory to the study structure-function relationship in key cancer proteins, as well as on the analyses of high-throughput sequencing and –omics data from profiling of cancer patients.

He is a Professor Emeritus since October 2007 . He was a Director of Scientific Computing Center at Ain Shams University (1984-1990).He is a Professor of Computer Science , since 1989 at Ain Shams University, Egypt. He has been involved in more than 400 international conferences and workshops as a keynote speaker, member of Scientific Program Committees, and Organizer and Session Chair. He is a member of many national and international informatics associations. He is a member of the editorial boards of many internal journals in the areas of ICT , Bio-medical Informatics and artificial intelligence. He has published around 350 papers in refereed journals and conferences.

His research includes: intelligent computing, knowledge-based systems , data mining , knowledge engineering , bio-medical and health,informatics, e-government, intelligent e-learning and artificial intelligence technologies.

Roumen Kountchev is a professor at the Faculty of Telecommunications, Department of Radio Communications and Video Technologies at the Technical University of Sofia, Bulgaria. Prof. Kountchev has 342 papers published in magazines and proceedings of conferences (72 international); 15 books (7 international); 45 book chapters; 20 patents (3 international). He had been principle investigator of 38 research projects (6 international). At present he is a member of Euro Mediterranean Academy of Arts and Sciences, President of Bulgarian Association for Pattern Recognition; Editorial board member of: Intern. Journal of Reasoning-based Intelligent Systems; Intern. Journal Broad Research in Artificial Intelligence and Neuroscience; KES Focus Group on Intelligent Decision Technologies; Egyptian Computer Science Journal; Intern. Journal of Bio-Medical Informatics and e-Health, and Intern. Journal Intelligent Decision Technologies.

Digital signal and image processing, image compression, multimedia watermarking, video communications, pattern recognition and neural networks.

Runsheng Chen, Principal Investigator at Institute of Biophysics, CAS, is an academician of the Chinese Academy of Sciences (CAS), and an academician of the International Eurasian Academy of Sciences. Prof. Chen is a member of Human Genome Organization (HUGO), a member of the biomacromolecule group of The Committee on Data for Science and Technology (CODATA), and a member of the bioinformatics professional committee of the International Union of Pure and Applied Physics (IUPAP). Prof. Chen is now the General-secretary and Vice president of Chinese Society of Biophysics, and has published more than 130 papers in SCI.

Chen is one of the pioneer scholars developing the researches on theoretical biology and bioinformatics in China. For more than thirty years, Prof. Chen has led his group to perform a series of systemic researches in the field of bioinformatics, since 2001, Prof. Chen has rapidly expanded his interest to the investigation of noncoding RNAs, two widely used noncoding RNA databases (NONCODE, http://www.noncode.org/, and NPInter, http://www.bioinfo.org/NPInter/) have been established and updated periodically; in addition, by developing Rnomics technology, including RNA library construction and custom-microarray-design etc., group of Prof. Chen has identified thousands of long noncoding RNAs associated with tumorigeneisis.

Jie Guo has completed her PhD at the age of 27 years from Beijing Normal University and postdoctoral studies from Institute of Botany, the Chinese Academy of Sciences. She is an Assistant Professor at Institute of Botany, the Chinese Academy of Sciences since 2011. She has published 7 papers in reputed journals and has been serving as a reviewer for many top international journals, including “Journal of Theoretical Biology”, “New Phytologist”, “Scientific Reports”, "Journal of Systematics and Evolution" and "Genomics Proteomics and Bioinformatics”.

Protein structure prediction, High-throughput data analyses, System biology, Comparative genomics, Population genomics and evolutionary biology

Prof. Miklas Scholz, cand ing, BEng (equiv), PgC, MSc, PhD, CWEM, CEnv, CSci, CEng, FHEA, FIEMA, FCIWEM, FICE, Fellow of IWA holds the Chair in Civil Engineering at The University of Salford. He is the Head of the Civil Engineering Research Group. Prof. Scholz has shown individual excellence evidenced by world-leading publications, postgraduate supervision and research impact. His main research areas in terms of publication output are as follow: treatment wetlands (19%), integrated constructed wetlands (ICW, 14%), sustainable flood retention basins (SFRB, 7%), permeable pavement systems (7%), decision support systems (6%), ponds (5%) and capillary suction time (6%). About 46% and 45% of his research is in water resources management and wastewater treatment, respectively. The remaining 9% are in capillary processes and water treatment. currently Professor in Civil Engineering, Chair in Civil Engineering and Head of the Civil Engineering Research Group, School of Computing, Science and Engineering, College of Science and Technology, The University of Salford, Salford, Greater Manchester M5 4WT, England, United Kingdom

His research has led to the incorporation of findings into national and international guidelines on wetland and sustainable drainage systems. The greatest impact has been made in the area of ICW in Ireland, Northern Ireland, Scotland and England. Prof. Scholz contributed to the design guidelines of wetland systems as a research consultant. The guidelines assist designers and managers in all aspects of ICW planning, design, construction, maintenance and management. Moreover, specific guidelines were written for ICW used by farmers to treat farm yard runoff in Scotland and Northern Ireland, and Ireland. These guidelines are specifically mentioned in national legislation.

He received his doctoral degree in 1977 from the Vienna University of Technology. From 1987 to 2012 he served as full professor at the Institute for Water Quality, Resource and Waste management at Vienna University of Technology, from 1994- 1998 as dean of the faculty of Civil Engineering and from 2004 to 2010 as vice chair of the senate. He was member of the Board of Directors of IWA for many years, chair of the IWA publishing committee until September 2014, since 2008 he is a IWA Distinguished Fellow . Actually he is president of IWA for the period 2014 to 2016.

His research field on municipal and industrial waste water treatment focused on biological process development from lab scale to full scale plant design and operation. His research on river basin management focused on the role of point and diffused nutrient sources on surface and ground waters. Teaching focused on basic and advanced education in Water Quality Management and doctoral programs. Another key aspect was the enhancement of continuous flow of knowledge and experience from reserach to full scale operation (professional training) together with the Austrian Water and Waste Association

Jingrang Lu is a biologist with the U.S. Environmental Protection Agency in Cincinnati, Ohio. His research work focuses on the molecular method development and detection of pathogenic bacteria in water, using transcriptomic, metagenomic and genomic analysis and host animal model, and to assess water quality and pathogenic risks. He holds a PhD in microbial ecology and a MS in zoology. He has over 60 peer reviewed publications. His main interests are to apply molecular approaches to applied environmental microbiology and public health researches.

Microbiology

Prof. Malka Halpern is is an Environmental Microbiologist at the University of Haifa. She has completed her PhD from Haifa University, Israel and her postdoctoral studies from Tel-Aviv University, Israel

Her main interests are the ecology of waterborne pathogens and in particular Vibrio cholerae, Aeromonas and Legionella, Plant-bacteria interactions and Bacterial taxonomy. She has published more than 49 papers in reputed journals.

Noreddin received his Ph.D. in Pharmaceutical Sciences from the University of the Pacific, California and received research training as a visiting scholar at the Department of Medicine, Stanford University. He had postdoctoral fellowship (Pharmacokinetics and Pharmacodynamics of Antimicrobials), Department of Medical Microbiology, University of Manitoba followed by an American College of Clinical Pharmacy postdoctoral fellowship (Infectious Diseases). Dr. Noreddin’s research interest includes Pharmacoklinetic/Pharmacodynamic modeling of anti-infective and anti-cancer therapy, clinical simulation and Monte Carlo analysis and bacterial resistance in biofilm studies. Dr. Noreddin has outstanding records of scientific and academic accomplishments with multiple research funding, numerous publications in highly prestigious journals and various presentations in both national and international conferences. He served as a scientific reviewer for the NIH as well as other national and international research institutions.

Pharmacokinetic/Pharmacodynamic modeling of anti-infective and anti-cancer therapy Clinical simulation and Monte Carlo analysis Bacterial resistance in biofilm studies Cancer epigenetic studies Minority health care studies

Zhou has authored more than 420 publications, with total citations of > 20,000 and H-index of 76 based on Google Scholar, 65 based on Web of Science. More than 50 papers were published in the high profile journals, namely Science (3), Nature Climate Change (1), PNAS (8), Nature Review in Microbiology (2), Nature Communications (1), mBio (6), Ecology Letters (1), PLoS Genetics (1), PLoS Pathogens (1), and The ISME Journal by Nature Publishing Group (30). One of his papers, published in 1996, is among the 20 most cited papers (>2,300 times) in the history of Applied and Environmental Microbiology since 2008. Invited Talks. Since 1995, 410 talks were given for university seminars and international conferences in various countries, with more than 300 talks since last 10 years, including an ASM Divisional lecturer, and Australia Society for Microbiology Visiting Speaker for cruise lectures to various institutions, and Special keynote talk at Chinese Academy of Sciences under the special seminar series, \"Sciences and China\". Funded Projects Since moving from Oak Ridge National Lab to OU (2006), Dr. Zhou has had 32 projects in genomics and microbial ecology, and has received a total funding of >$27M.

Dr. Zhou established a Fellowship at the School of Environment, Tsinghua University, with main purposes to recognize excellent graduate students in microbial ecology and environmental science at Tsinghua University, and possibly award young microbial ecologists across China. Dr. Zhou also initiated the establishment of Global Water Microbiome Consortium (GWMC) as a platform to facilitate international collaboration and communication on research and education on global water microbiome studies

*Dr. Mahmoud currently holds the position of a professor in the department of parasitology in the University of Cairo since 2004. Her field of specialization is Fish Parasitology. She joined as an Assistant Lecturer from 1990 to 1994. Lecturer of Parasitology since 1994. Assistant Professor of Parasitology since Sept.1999. Prof. of Parasitology since 2004.She had received her MVSc (Parasitology, fish parasites) in 1990 and PhD (Parasitology, fish parasites) from Cairo University in 1994. **She is the chair and member of the following commitees & associations: *Charing in the project of Biotechnological control of ticks in Egypt ( from 1995-1996). *Charing in the project of Geographical imfomation systems (GIS) and control of snail borne diseases. *Member of the Egyptian Vet. Med. Assoc. *Member of the zoological society A. R. Egypt. Member of fish committee of the general organization for veterinary services, Egypt.(G.O.Vet.S.) *Member of the fish committee for the solution of Lake Naser fish helminth problems in G. O. Vet. S. Egypt. *Attemptin a training course on fish Parasites in General Authority for Fish Resources Development 2002. *Member of the Egyptian Society of Veterinary Parasitology. *Member of the Egyptian Society of Parasitology. *Charring in the Project Comparative study of Lime Borreliosis Vectors/ Pathogenesis (Egyptian/US Project # 930312. from 1999-2002). *Member of the Egyptian Society of Environment and Aquatic Animal Health. *Head of the Egyptian society of parasitology and pathology of aquatic organisms. *Editor in Oceanography journal. *Member of the organization committee of Oceanography conference 2013 and 2014.

Fish Parasitology

Paul L. Hermonat completed his Ph.D. at the University of Florida in 1984, and postdoctoral studies at the National Institutes of Health. He is a professor of Internal Medicine and OB/GYN at the University of Arkansas for Medical Sciences and a Research Career Scientist at the Central Arkansas Veterans Healthcare System. He was the first to generate recombinant adeno-assocociated virus (AAV/NeoR) and to transfer genes into cells via this method. He has over 140 manuscripts published, mostly on the topic of AAV molecular biology and gene transfer.

gene therapy, molecular biology

Johan was appointed Chief Scientific Officer of the Cell Therapy Catapult in May 2013. As Chief Scientific Officer, he is responsible for external scientific relations, assessment of candidate projects and technical oversight of preclinical programs. He has extensive experience of the life sciences industry, having worked in cell and tissue companies in Europe and the US for over 15 years. Johan has been involved in numerous transactions and collaborations, establishment of scientific facilities, and the management of scientific programs in industry and academia. He has published more than 60 full length scientific papers.

Stem cells, Regenerative medicine.

Munis Dundar was born in 1961. He graduated from Faculty of Medicine, Erciyes University (Turkey) in 1985. He obtained his Ph.D in Genetics from the Glasgow University (UK) in 1994 and M.D in Clinical Genetics in Faculty of Medicine, Osmangazi University (Turkey). He is president of the European Biotechnology Thematic Network Association (EBTNA). He is a board of he European Predictive, Preventive and Personalized Medicine Association (EPMA) and EPMA Journal.

His Research of Interest are Biotechnology, Cancer, Medicine etc.

Nagy Habib, Professor of Hepatobiliary Surgery at Imperial College London is a translational researcher who pioneered the first clinical trial in the use of adenovirus and plasmid for the treatment of liver cancer, and the use of plasmid gene therapy in hydrodynamic gene delivery. He was also the first to publish from the West a clinical trial on the use of adult bone marrow-derived stem cells for the treatment of patients with liver insufficiency. He has published on the evolution of molecular biology of tumours (oncogene, tumour suppressor gene, epigenetic modification), gene therapy, stem cell therapy, saRNA and RNAaptamers.

liver cancer and its treatment, tumors from oncogene, tumor suppressor gene, epigenetic modification, genetherapy, stem cell therapy, RNA (Ribonucleic acid) and saRNA (small activating RNA) and RNA aptamers.

Giulio Maria Pasinetti is the Saunders Family Chair and Professor of Neurology (Mount Sinai) and Director of Basic and Biomedical Research and Training (GRECC, Bronx VA Medical Center). His research on co-morbidities influencing neurodegeneration has made him one of the top experts in his field. His principal focus is the prevention of neurodegenerative disorders even before the disease becomes symptomatic and drug discovery and screening. He is the recipient of many awards, including the Zenith and Temple awards from the Alzheimer’s Association and the Faculty Council Award for academic excellence at Mount Sinai. Dr. Pasinetti is the recipient of over 30 grants and has published over 300 groundbreaking manuscripts.

His research on co-morbidities influencing neurodegeneration has made him one of the top experts in his field. His principal focus is the prevention of neurodegenerative disorders even before the disease becomes symptomatic and drug discovery and screening.

Vasiliki E. Kalodimou MSc, Ph.D is the director of the Flow Cytometry-Research and Regenerative Medicine Department at IASO Hospital in Athens, Greece. She has studied and worked with progenitor cells from placenta, umbilical cord, and adipose tissue along with their applications in regenerative medicine and flow cytometry, with publications in the field, including research fellowships. She has published 2 books about flow cytometry, the Greek edition was published in 2010 and in 2013 the book was published from AABB Press USA. She is a Flow Cytometry Specialist, Associate Leader at AABB CT Subsection: CT Product Manufacturing and Testing, USA, Scientific Consultant in Regenerative Plastic Surgery Institute / Pure Aesthetics, Brazil, AABB Assessor, USA, editor in 3 scientific journals and her biography was included in Who Is Who in the world 2014 & 2015edition.

She has studied and worked with progenitor cells from placenta, umbilical cord, and adipose tissue along with their applications in regenerative medicine and flow cytometry.

Venkatachalam K.V. is a professor in Department of Biochemistry at Nova Southeastern University, USA

His Research Interest is Cancer, Molecular Biology etc

Dr. Nady Golestaneh is an Assistant Professor at Georgetown University School of Medicine Department of Biochemistry and Molecular Cellular Biology She received her PhD and MS degrees in Biology and Pharmacology of Aging from University of Paris VI Pierre et Marie Curie in Paris France and her BS in Cellular Biology and Biochemistry from University of Paris VII Jussieu in Paris France She performed postdoctoral training at NIH NEI and Johns Hopkins University before joining Georgetown University School of Medicine in 2005 Recently she has shown that male germline stem cells can become pluripotent capable of differentiating into the three primordial germ layers offering the possibility of autologous cellbased therapy in degenerative diseases In parallel Golestaneh’s lab has demonstrated that the iPS cells can be differentiated into functional retinal pigment epithelium that could be prominent candidates for regeneration therapies in agerelated macular degeneration AMD Dr Golestaneh’s innovative work in the area of stem cells research has earned her several prestigious national and international awards and her research is supported by NIH grant.

Her area of research interest is mainly on stem cells, autologous cellbased therapy in degenerative diseases

Dr. Uday Kishore, a cellular and molecular immunologist, is the Director of the Centre for Infection, Immunity and Disease Mechanisms, Brunel University, London. He researches on the role of innate immunity in a range of disease processes and therapeutic interventions. He earned his MSc and PhD from University of Delhi, India. He has previously been a NASA Fellow at Salk Institute, USA, MRC Fellow at Oxford, and Humboldt Fellow in Germany. He has authored over 100 research papers, 20 book chapters, 2 patents and edited 3 books. He is also the recipient of MRC Inventor’s prize, European Commission Young Scientist prize, and, more recently, Mother Teresa Excellence Award 2014.

cellular and molecular immunology

Samir A Farghaly is a Physician/Scientist,  and faculty member of the Medical College of Cornell University and The New York Presbyterian Hospital /Cornell University Medical Center, New York, NY, USA. He received his M.D Degree from University College London University (1985), and his PhD Degree in molecular biology from London university (1993). He received several clinical and research awards. He has been an invited speaker in several national and international conferences on cancer. He is a member of several national and international societies, organization and foundation of cancer and women health . He is an editor, member of editorial boards and reviewers of several medical journals of Oncology, Gynecology and Gynecological Cancers. He has published 74 articles. He is an editor of a book on ovarian cancer.

Bio markers profile, and screening for ovarian cancer. Mutant BRCA1 and BRCA2 genes profiles in ovarian cancer. Proteomic profiling of metastatic genes of ovarian cancer. Targeted molecular therapy for advanced epithelial ovarian cancer. Minimally invasive surgery for gynecological cancer.